USD 0.0
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2013 | 12.64 Million USD | 4.44% |
2012 | 12.1 Million USD | 0.47% |
2011 | 12.05 Million USD | 528.59% |
2010 | 1.91 Million USD | -4.01% |
2009 | 1.99 Million USD | -9.88% |
2008 | 2.21 Million USD | -39.0% |
2007 | 3.63 Million USD | -23.96% |
2006 | 4.77 Million USD | 21.95% |
2005 | 3.91 Million USD | -34.27% |
2004 | 5.96 Million USD | 9.3% |
2003 | 5.45 Million USD | -19.28% |
2002 | 6.75 Million USD | -9.79% |
2001 | 7.49 Million USD | 1.89% |
2000 | 7.35 Million USD | 130.77% |
1999 | 3.18 Million USD | -8.99% |
1998 | 3.5 Million USD | -16.67% |
1997 | 4.2 Million USD | 31.25% |
1996 | 3.2 Million USD | 77.78% |
1995 | 1.8 Million USD | 100.0% |
1994 | 900 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2014 Q3 | 13.08 Million USD | 0.24% |
2014 Q2 | 13.05 Million USD | 1.07% |
2014 Q1 | 12.91 Million USD | 2.16% |
2013 Q3 | 12.8 Million USD | 0.91% |
2013 Q1 | 12.74 Million USD | 5.28% |
2013 Q2 | 12.69 Million USD | -0.42% |
2013 Q4 | 12.64 Million USD | -1.28% |
2013 FY | 12.64 Million USD | 4.44% |
2012 Q2 | 13.4 Million USD | 2.47% |
2012 Q3 | 14.68 Million USD | 9.51% |
2012 FY | 12.1 Million USD | 0.47% |
2012 Q1 | 13.08 Million USD | 8.6% |
2012 Q4 | 12.1 Million USD | -17.55% |
2011 FY | 12.05 Million USD | 528.59% |
2011 Q1 | 8.85 Million USD | 362.02% |
2011 Q3 | 11.29 Million USD | 8.31% |
2011 Q4 | 12.05 Million USD | 6.73% |
2011 Q2 | 10.42 Million USD | 17.69% |
2010 Q3 | 1.99 Million USD | -1.97% |
2010 Q4 | 1.91 Million USD | -3.67% |
2010 FY | 1.91 Million USD | -4.01% |
2010 Q2 | 2.03 Million USD | 12.28% |
2010 Q1 | 1.8 Million USD | -9.46% |
2009 FY | 1.99 Million USD | -9.88% |
2009 Q1 | 2.14 Million USD | -3.11% |
2009 Q2 | 1.95 Million USD | -8.99% |
2009 Q3 | 2.12 Million USD | 8.85% |
2009 Q4 | 1.99 Million USD | -6.11% |
2008 Q4 | 2.21 Million USD | -9.48% |
2008 FY | 2.21 Million USD | -39.0% |
2008 Q3 | 2.44 Million USD | -7.24% |
2008 Q2 | 2.63 Million USD | 3.78% |
2008 Q1 | 2.54 Million USD | -30.0% |
2007 Q2 | 2.54 Million USD | -40.05% |
2007 Q4 | 3.63 Million USD | 34.31% |
2007 FY | 3.63 Million USD | -23.96% |
2007 Q1 | 4.24 Million USD | -11.22% |
2007 Q3 | 2.7 Million USD | 6.37% |
2006 Q3 | 3.21 Million USD | -0.92% |
2006 Q2 | 3.24 Million USD | 8.93% |
2006 Q1 | 2.98 Million USD | -23.94% |
2006 FY | 4.77 Million USD | 21.95% |
2006 Q4 | 4.77 Million USD | 48.57% |
2005 Q4 | 3.91 Million USD | -27.23% |
2005 FY | 3.91 Million USD | -34.27% |
2005 Q3 | 5.38 Million USD | -0.57% |
2005 Q1 | 5.47 Million USD | -8.12% |
2005 Q2 | 5.41 Million USD | -1.13% |
2004 Q3 | 4.67 Million USD | 3.64% |
2004 FY | 5.96 Million USD | 9.3% |
2004 Q1 | 4.64 Million USD | -14.91% |
2004 Q4 | 5.96 Million USD | 27.56% |
2004 Q2 | 4.5 Million USD | -2.84% |
2003 Q1 | 5.99 Million USD | -11.32% |
2003 Q3 | 5.02 Million USD | -5.62% |
2003 Q2 | 5.32 Million USD | -11.2% |
2003 FY | 5.45 Million USD | -19.28% |
2003 Q4 | 5.45 Million USD | 8.6% |
2002 Q1 | 7.34 Million USD | -1.91% |
2002 Q4 | 6.75 Million USD | 3.1% |
2002 Q3 | 6.55 Million USD | -13.17% |
2002 Q2 | 7.54 Million USD | 2.74% |
2002 FY | 6.75 Million USD | -9.79% |
2001 Q2 | 7.33 Million USD | -2.28% |
2001 Q1 | 7.5 Million USD | 2.11% |
2001 Q3 | 7.53 Million USD | 2.74% |
2001 Q4 | 7.49 Million USD | -0.61% |
2001 FY | 7.49 Million USD | 1.89% |
2000 Q4 | 7.35 Million USD | 3.1% |
2000 Q3 | 7.13 Million USD | -1.95% |
2000 Q2 | 7.27 Million USD | 136.33% |
2000 Q1 | 3.07 Million USD | -3.41% |
2000 FY | 7.35 Million USD | 130.77% |
1999 Q4 | 3.18 Million USD | 23.24% |
1999 FY | 3.18 Million USD | -8.99% |
1999 Q1 | 3 Million USD | -14.29% |
1999 Q2 | 2.5 Million USD | -16.67% |
1999 Q3 | 2.58 Million USD | 3.39% |
1998 Q1 | 3.5 Million USD | -16.67% |
1998 Q2 | 3.3 Million USD | -5.71% |
1998 Q3 | 3.6 Million USD | 9.09% |
1998 FY | 3.5 Million USD | -16.67% |
1998 Q4 | 3.5 Million USD | -2.78% |
1997 Q3 | 2.9 Million USD | -19.44% |
1997 Q2 | 3.6 Million USD | 44.0% |
1997 FY | 4.2 Million USD | 31.25% |
1997 Q4 | 4.2 Million USD | 44.83% |
1997 Q1 | 2.5 Million USD | -21.88% |
1996 Q3 | 3 Million USD | 20.0% |
1996 Q1 | 2.2 Million USD | 22.22% |
1996 Q2 | 2.5 Million USD | 13.64% |
1996 Q4 | 3.2 Million USD | 6.67% |
1996 FY | 3.2 Million USD | 77.78% |
1995 Q4 | 1.8 Million USD | 0.0% |
1995 FY | 1.8 Million USD | 100.0% |
1994 Q4 | 900 Thousand USD | 0.0% |
1994 FY | 900 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Avitar, Inc. | 11.59 Million USD | -9.061% |
BioElectronics Corporation | 16.62 Million USD | 23.936% |
CVR Medical Corp. | - USD | -Infinity% |
IR-Med Inc. | 634 Thousand USD | -1894.322% |
Medical Supply International USA, Inc. | 677.61 Thousand USD | -1765.954% |
Polarean Imaging plc | 2.58 Million USD | -389.975% |
AVITA Medical, Inc. | 19.86 Million USD | 36.352% |
Manhattan Scientifics, Inc. | 2.11 Million USD | -496.978% |
Össur hf. | 688.8 Million USD | 98.164% |
Zecotek Photonics Inc. | 5.86 Million USD | -115.452% |
QHSLab, Inc. | 2.05 Million USD | -514.667% |
Wellstar International, Inc. | 55.99 Million USD | 77.418% |
Össur hf. | 688.8 Million USD | 98.164% |
Bionovate Technologies Corp | - USD | -Infinity% |
EKF Diagnostics Holdings plc | 16.08 Million USD | 21.371% |
Escalon Medical Corp. | 2.94 Million USD | -328.851% |
Aurora Spine Corporation | 6.65 Million USD | -90.034% |
BrainsWay Ltd. | 15.31 Million USD | 17.435% |
Lattice Biologics Ltd. | - USD | -Infinity% |
NewCardio, Inc. | 6.01 Million USD | -110.29% |
Hamilton Thorne Ltd. | 45.84 Million USD | 72.419% |
Vivos Inc. | 245 Thousand USD | -5060.732% |
MicroPort Scientific Corporation | 2.48 Billion USD | 99.491% |
Kelyniam Global, Inc. | 1.01 Million USD | -1148.254% |
REMSleep Holdings, Inc. | 275.61 Thousand USD | -4487.575% |
CYduct Diagnostics, Inc. | 2.44 Million USD | -416.122% |
Nanomix Corporation | 14.81 Million USD | 14.653% |
Theraclion SA | 13.01 Million EUR | 2.862% |
Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
Wellness Center USA, Inc. | 5.12 Million USD | -146.751% |
Positron Corporation | 2.02 Million USD | -524.087% |
Rafina Innovations Inc. | - USD | -Infinity% |
Electromedical Technologies, Inc. | 3.62 Million USD | -249.169% |
Lombard Medical, Inc. | 53.79 Million USD | 76.496% |
ALR Technologies Inc. | 24.5 Million USD | 48.403% |
Stratec SE | 271.97 Million USD | 95.351% |
Vycor Medical, Inc. | 4.31 Million USD | -192.836% |
Heart Tronics, Inc. | 1.09 Million USD | -1054.926% |
Nu-Med Plus, Inc. | 2.35 Million USD | -436.038% |
Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -130.875% |
SANUWAVE Health, Inc. | 65.59 Million USD | 80.724% |
VMS Rehab Systems, Inc. | 201.36 USD | -6279200.755% |
Guided Therapeutics, Inc. | 5.47 Million USD | -130.941% |
Ingen Technologies, Inc. | 5.7 Million USD | -121.454% |
Odyssey Group International, Inc. | 6.61 Million USD | -91.236% |
United American Healthcare Corporation | 119 Thousand USD | -10525.21% |
ECGI Holdings, Inc. | 11.94 Million USD | -5.893% |
Capital Group Holdings, Inc. | 1.32 Million USD | -854.996% |
ADM Tronics Unlimited, Inc. | 1.44 Million USD | -774.208% |
Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -134.319% |
Nexeon MedSystems Inc. | 8.48 Million USD | -49.061% |
SS Innovations International, Inc. | 11.18 Million USD | -13.084% |
Qualis Innovations, Inc. | 525.38 Thousand USD | -2306.607% |
Smith & Nephew plc | 4.76 Billion USD | 99.735% |
NIOX Group Plc | 9.8 Million USD | -28.993% |
Fuse Medical, Inc. | 15.11 Million USD | 16.321% |
Broncus Holding Corporation | 10.43 Million USD | -21.202% |
Brain Scientific Inc. | 7.42 Million USD | -70.257% |
Pressure BioSciences, Inc. | 33.8 Million USD | 62.596% |
Health Logic Interactive Inc. | 794.08 Thousand USD | -1492.281% |